The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Purpose: Thyroid hormones (THs) are primarily responsible for the regulation of energy balance and metabolism, suggesting that TH levels may contribute to the development of type 2 diabetes mellitus (T2DM). However, few studies have investigated the relationship between TH and T2DM in a general population. The aim of this study was to evaluate whether serum TH levels within the reference range are related to T2DM. Methods: A cross-sectional study (n = 15,296) was performed in Tianjin, China. Serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) levels were measured by chemiluminescence immunoassay, and T2DM was defined according to the American Diabetes Association criteria. Multiple logistic regression models were used to assess the sex-specific relationships between FT3, FT4, FT3/FT4 ratios, and TSH quintiles and T2DM. Results: The prevalence of T2DM was 16.2% in males and 7.7% in females. In males, the multivariable-adjusted odds ratios (95% confidence interval) of T2DM for increasing quintiles of FT3, FT4, and FT3/FT4 ratios were 1.00, 0.75(0.63 to 0.89), 0.70(0.58 to 0.84), 0.63(0.52 to 0.76), 0.56(0.46 to 0.68; P for trend < 0.0001); 1.00, 1.05(0.87 to 1.27), 1.16(0.96 to 1.40), 1.09(0.90 to 1.31), 1.29(1.07 to 1.56; P for trend = 0.01); and 1.00, 0.69(0.58 to 0.83), 0.72(0.60 to 0.86), 0.59(0.48 to 0.71), and 0.55(0.46 to 0.66; P for trend < 0.0001), respectively. Similar results also were observed in females. In contrast, a strong negative correlation between TSH and T2DM was observed in males, but not in females. Conclusions: This study demonstrated that decreased FT3, FT3/FT4 ratios, and increased FT4 levels are independently related to a higher prevalence of T2DM in both males and females, and TSH is inversely related to T2DM in males only.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · cited 2×
“Type 2 diabetes mellitus (T2DM) is the most common chronic endocrine disease, characterized by hyperglycemia resulting from impaired insulin secretion and/or insulin resistance (1).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Prevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Leon, B. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i13.1246 · Cited by 1,215 · cited 1×
“The long-term complications of T2DM can significantly increase the risks of cardiovascular disease (CVD), and cancer among many other diseases, as well as significantly increase risk of mortality (2, 3).”
BackgroundCellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891 · cited 2×
“the regulation of basal metabolic rate by deiodinasemediated TH signaling (49).”
BackgroundKnudsen, N., Laurberg, P., Rasmussen, L. B., Bülow, I., Perrild, H., Ovesen, L., & Jørgensen, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2225 · Cited by 753 · cited 9×
“Because studies have shown that serum TH and TSH levels are related to age (20) and BMI (21),”
BackgroundInfluentialGarduño-Garcia, J. D. J., Alvirde-Garcia, U., López-Carrasco, G., Padilla Mendoza, M. E., Mehta, R., Arellano-Campos, O., Choza, R., Sauque, L., Garay-Sevilla, M. E., Malacara, J. M., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0312 · Cited by 268 · cited 2×
“Four cross-sectional studies reported that serum FT4 was negatively related to insulin resistance, fasting insulin or the homoeostasis model assessment index for insulin resistance (HOMA-IR), while a positive relationship was found between TSH and insulin resistance (26-29).”
BackgroundAn approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits
Boucai, L., Hollowell, J. G., & Surks, M. I. (2011) · Thyroid · doi:10.1089/thy.2010.0092 · Cited by 235 · cited 1×
“) can regulate the thyroid function (34),”
Insulin Action in Adipose Tissue and Muscle in Hypothyroidism
Dimitriadis, G., Mitrou, P., Lambadiari, V., Boutati, E., Maratou, E., Panagiotakos, D. B., Koukkou, E., Tzanela, M., Thalassinos, N., & Raptis, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0478 · Cited by 233 · cited 1×
“Thyroid dysfunction increases muscle and adipose tissue insulin resistance (7) and decreases glucose transport in myocytes (8).”
Background
Cited by
Thyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598
Kalra, S., Aggarwal, S., & Khandelwal, D. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00700-4 · Cited by 128
Hu, W., Song, R., Cheng, R., Liu, C., Guo, R., Tang, W., Zhang, J., Zhao, Q., Li, X., & Liu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.927859 · Cited by 127
“Study Selection The trials we included met the following criteria: (1) RCTs that compared GLP-1 receptor agonist with a placebo or active control (other antidiabetic drugs or insulin), (2) patients with type 2 diabetes, type 1 diabetes, prediabetes, overweight or obesity, (3) with durations of at least 24 weeks, and (…”
BackgroundMethod
Metadata
- Authors
- Gu, Y., Li, H., Bao, X., Zhang, Q., Liu, L., Meng, G., Wu, H., Du, H., Shi, H., Xia, Y., Su, Q., Fang, L., Yu, F., Yang, H., Yu, B., Sun, S., Wang, X., Zhou, M., Jia, Q., Guo, Q., Chang, H., Wang, G., Huang, G., Song, K., & Niu, K.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-12
- Volume
- 102
- Issue
- 2
- Pages
- jc.2016-2965
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2558262944
- Cited by
- 124
- References
- 12
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects. https://app.cochat.ai/papers/10.1210/jc.2016-2965
- The paper
- Gu, Y., Li, H., Bao, X., Zhang, Q., Liu, L., Meng, G., Wu, H., Du, H., Shi, H., Xia, Y., Su, Q., Fang, L., Yu, F., Yang, H., Yu, B., Sun, S., Wang, X., Zhou, M., Jia, Q., . . . Niu, K. (2016). The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2016-2965
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.